Target gene: esrp1 (Epithelial Splicing Regulatory Protein 1), Callorhinchus milii (elephant shark; NCBITaxon:7868)
UniProt accession: A0A4W3GVU1 (684 aa)
Focus: computational_prediction — prediction-nucleus-localization
Term under evaluation: nucleus (GO:0005634)
Prediction source: ProtNLM2
The ProtNLM2 prediction of nuclear localization (GO:0005634) for the elephant shark RRM-containing protein A0A4W3GVU1 is SUPPORTED. The prediction is correct in substance and rests on a sound orthology-based foundation rather than being a bare name-model guess. A0A4W3GVU1 is an unambiguous ortholog of ESRP1 — pairwise global alignment gives ~78% identity to human ESRP1 (Q6NXG1) versus only ~60% to the paralog ESRP2 (Q9H6T0) — and the experimentally characterized human ortholog carries a direct experimental nuclear localization annotation (UniProt SUBCELLULAR LOCATION = Nucleus, ECO:0000269; GO cellular-component nucleus IDA, plus more specific nucleoplasm and nuclear body IDA from the Human Protein Atlas). Because ESRP1 is a splicing regulator that must reach pre-mRNA in the nucleus to perform its core function, nuclear localization is intrinsic to its direct molecular activity rather than a downstream phenotype.
Three computational analyses run during this investigation reinforce the call. First, the shark protein is a soluble RNA-binding protein: a Kyte–Doolittle hydropathy scan (window 19) gave a maximum hydropathy of 1.45 (below the 1.6 transmembrane threshold) and zero predicted transmembrane segments — the correct biophysical class for a nuclear splicing factor and inconsistent with any membrane-embedded localization. Second, all three RNA recognition motifs are intact, carrying the diagnostic ESRP-type β1 "RGLP" signatures (residues 228, 329, 448) and conserved C-terminal aromatic "RY[IV]E[VL]" motifs (residues 291, 395, 514), supporting retained sequence-specific RNA binding. Third, no strong classical nuclear localization signal (NLS) is present — only a weak monopartite-like "KKHK" cluster inside RRM2 near residue 385 — which is fully consistent with ESRP1's known non-canonical, isoform-dependent nuclear targeting and is not evidence against nuclear localization.
The single most important caveat is scope. ESRP1 is functionally nucleocytoplasmic, not nucleus-exclusive: Yang & Carstens (2017) showed that alternative 5′ splice-site usage in exon 12 produces isoforms with differential nucleocytoplasmic localization, with the nuclear pool driving epithelial-specific splicing (PMID: 28634384). Nucleus is therefore the dominant and functionally primary localization but not the only one. Additionally, "nucleus" is a relatively coarse cellular-component term — the ortholog evidence would equally support the more specific nucleoplasm (GO:0005654) and nuclear body (GO:0016604), and the truly core annotations of this gene are its molecular-function term (sequence-specific mRNA binding) and biological-process term (regulation of alternative mRNA splicing). The recommendation to the curator is to retain nucleus as an ISS annotation, optionally add the more specific CC terms, prioritize the core MF/BP terms, and record that the localization is nucleocytoplasmic.
Verdict: SUPPORTED (primary/dominant localization; the prediction is correct but low in added information relative to existing orthology-based knowledge).
The nucleus prediction is correct and well-supported. The reasoning chain is:
Most important caveats: (i) ESRP1 is nucleocytoplasmic — a conserved cytoplasmic isoform pool exists (PMID 28634384), so nucleus is dominant but not exclusive; (ii) the ProtNLM2 nucleus call essentially restates well-established orthology knowledge and is less informative than the specific CC terms (nucleoplasm/nuclear body) and the core MF/BP terms; (iii) the absence of a canonical NLS is expected for ESRP1 and is not a conflict.
The first question for any localization prediction on a poorly annotated non-model-organism protein is whether the protein is what its name claims. For A0A4W3GVU1 the answer is clearly yes, and this matters because paralog misassignment is the leading source of erroneous functional and localization transfer.
UniProt/InterPro place the protein in the ESRP family (IPR050666), and it carries the ESRP1-specific RRM1 signature IPR034427 (ESRP1_RRM1), which distinguishes it from ESRP2. It contains three RRM domains (three copies of SMART SM00360; three Pfam RRM matches) and is 684 aa long — the same size class as human ESRP1 (681 aa). Orthology was confirmed quantitatively rather than by name: Needleman–Wunsch global alignment gave ~78% identity to human ESRP1 (Q6NXG1) versus only ~60% to human ESRP2 (Q9H6T0, 727 aa). A composition-based cross-check using 5-mer Jaccard similarity gave 22.3% overlap with ESRP1 versus 9.7% with ESRP2, a >2-fold preference. The shark protein is therefore firmly ESRP1, not ESRP2.
Biophysically, the Kyte–Doolittle hydropathy scan (window 19) gave a maximum of 1.45 (below the 1.6 transmembrane threshold) and 0 predicted transmembrane segments — a soluble RNA-binding protein, exactly the class expected for a nuclear/nucleocytoplasmic splicing regulator and inconsistent with membrane-embedded localization. Yang & Carstens describe ESRP1 as containing "three highly conserved RNA recognition motifs (RRMs) in the absence of other clearly defined protein domains" (PMID: 28634384), matching the shark protein's domain content.
An annotated domain is not necessarily an intact one. A direct motif scan of A0A4W3GVU1 confirmed that all three RRMs retain their diagnostic ESRP-type residues. Three ESRP-type RRM β1 signatures ("RGLP") were located at residues 228, 329, and 448, each paired with a conserved C-terminal RRM aromatic motif "RY[IV]E[VL]" at residues 291 (RYIEVY), 395 (RYIELF), and 514 (RYVEVF). The presence of the aromatic ribonucleoprotein-submotif residues across all three RRMs indicates the RNA-binding surfaces are preserved, supporting sequence-specific mRNA binding as the retained core molecular function. This is directly relevant to localization: a functional splicing regulator with intact RNA-binding modules is expected to act on nuclear pre-mRNA, which is mechanistically consistent with the nuclear call.
The prediction is not merely plausible; it is directly corroborated by the biology of the family, with a refinement. Yang & Carstens showed that "two competing alternative 5′ splice sites in exon 12 yield Esrp1 isoforms with differential nucleocytoplasmic localization," and that the nuclear pool drives epithelial-specific splicing: "while previous studies have described extensive regulation by nuclear Esrp1 to promote epithelial specific splicing" (PMID: 28634384). They also identified a peptide sufficient for nuclear localization that is conserved to the Drosophila ortholog fusilli.
Computationally, the shark sequence has no strong classical NLS — only a weak monopartite-like "KKHK" cluster within RRM2 near residue 385, and no bipartite NLS. This is consistent with ESRP1's non-canonical, isoform-dependent nuclear targeting rather than a simple importin-α/β classical NLS. The C-terminal Pro/Tyr/Ser-rich low-complexity region (~residues 520–620) corresponds to the exon-12 localization-regulating region characterized in mammals. Thus the sequence evidence supports nuclear localization as the dominant, splicing-active state while explaining why a naïve NLS search finds no canonical signal.
The strongest anchor for the shark annotation is experimental data on its close ortholog. UniProt Q6NXG1 (human ESRP1) records SUBCELLULAR LOCATION = Nucleus with experimental evidence (ECO:0000269), and its GO cellular-component annotations include nucleus (GO:0005634, IDA:UniProtKB), nucleoplasm (GO:0005654, IDA:HPA), nuclear body (GO:0016604, IDA:HPA), and ribonucleoprotein complex (GO:1990904, IBA). At ~78% identity, the ISS transfer of nucleus to the shark protein is well justified — this is the difference between an unsupported computational guess and an evidence-backed cross-species annotation.
The findings assemble into a coherent picture of an epithelial splicing regulator whose primary functional site is the nucleus:
Elephant shark A0A4W3GVU1 (ESRP1 ortholog, 684 aa)
┌────────────────────────────────────────────────────────────┐
│ RRM1 RRM2 (weak KKHK ~385) RRM3 LCR (Pro/Tyr/ │
│ ~228 ~329 ~448 Ser ~520–620) │
│ RGLP RGLP + weak NLS RGLP exon-12-like │
│ RYIEVY RYIELF RYVEVF localization reg│
└────────────────────────────────────────────────────────────┘
│ │
│ sequence-specific RNA binding │ isoform-specific
│ (3 intact RRMs) │ nucleocytoplasmic control
▼ ▼
── NUCLEUS (dominant) ───────────► epithelial-specific alternative
pre-mRNA splicing regulation splicing program
│ (FGFR2, CD44, ENAH, Arhgef11)
└── CYTOPLASM (minor isoform pool) — mRNA-stability / non-splicing roles
The immediate molecular function being localized is sequence-specific RNA binding by three intact RRMs. The immediate cellular process is regulation of alternative pre-mRNA splicing, which occurs in the nucleus. Nuclear localization is thus a direct requirement of the protein's core activity — the splicing-competent pool must be nuclear to reach pre-mRNA — not a downstream phenotype. The cytoplasmic isoform pool (generated by exon-12 alternative 5′ splice-site choice) represents a context-specific, likely non-splicing role and is why "nucleus" should be read as dominant rather than exclusive.
The table below shows how each localization hypothesis fares against the assembled evidence:
| Localization hypothesis | Sequence/architecture support | Ortholog experimental support | Verdict |
|---|---|---|---|
| Nucleus (GO:0005634) — splicing pool | Soluble 3-RRM RBP; exon-12-like LCR; weak KKHK | Human ESRP1 nucleus IDA (ECO:0000269) | Supported, dominant |
| Nucleoplasm / nuclear body (more specific CC) | Consistent with a splicing factor | Human ESRP1 nucleoplasm & nuclear body IDA (HPA) | Supported, more informative |
| Cytoplasm / nucleocytoplasmic | LCR / exon-12 region present | Isoform-specific cytoplasmic pool (PMID 28634384) | Partial — minor pool |
| Membrane / secreted | 0 TM segments; no signal peptide | — | Refuted |
| Citation | Evidence type | Direction | Claim tested | Key finding | Context | Confidence / limitations |
|---|---|---|---|---|---|---|
| UniProt Q6NXG1 (human ESRP1) | Localization (IDA) / database-experimental | Supports | Is nuclear localization experimentally real? | Human ortholog: SUBCELLULAR LOCATION Nucleus (ECO:0000269); GO nucleus IDA, nucleoplasm IDA, nuclear body IDA | Human cells (incl. HPA) | High; ISS transfer to shark |
| UniProt/InterPro (A0A4W3GVU1) | Database / structural | Supports | Identity & architecture | Family IPR050666 (ESRP), ESRP1-specific RRM1 (IPR034427), 3 RRM domains, 684 aa; existing GO nucleus (IEA), RNA binding, mRNA splicing | Elephant shark | High; IEA-level for GO |
| Computed (this run) | Computational / evolutionary | Supports | Is it ESRP1 not ESRP2? | NW identity ~78% to ESRP1 vs ~60% to ESRP2; 5-mer Jaccard 22.3% vs 9.7% | Cross-species | High; conservative identity scoring |
| Computed (this run) | Computational | Qualifies | Membrane vs soluble | Max KD hydropathy 1.45 (<1.6); 0 TM segments → soluble RBP | Sequence | High |
| Computed (this run) | Computational | Qualifies | Presence of classical NLS | No bipartite NLS; only weak monopartite-like "KKHK" inside RRM2; C-term Pro/Tyr/Ser LCR (~520–620) | Sequence | Medium; motif scan, not trained predictor |
| Computed (this run) | Computational / structural | Supports | Are the three RRMs intact? | Three ESRP-type RRM β1 "RGLP" motifs (228/329/448) and three "RY[IV]E[VL]" aromatic motifs (291/395/514) → 3 intact RRMs | Sequence | High; motif-based |
| PMID: 28634384 (Yang & Carstens 2017) | Localization / direct assay | Supports + qualifies | Where does ESRP1 localize? | Exon-12 alt 5′ splice sites yield isoforms with differential nucleocytoplasmic localization; NLS peptide identified; conserved to Drosophila fusilli | Mammalian + fly | High; primary literature |
| PMID: 26371508 (Bebee 2015) | Mutant phenotype | Supports (BP context) | ESRP function | Esrp1/2 direct an epithelial splicing program essential for development | Mouse | High |
| PMID: 30485810 (Lee 2018) | Mutant phenotype | Supports (BP context) | Nuclear splicing activity | Esrp1-regulated Arhgef11 splicing required for tight-junction integrity | Mouse epithelia | High |
| PMID: 27404344 (Bebee 2016) | Mutant phenotype | Supports (BP context) | Splicing regulation | Esrp1 controls Fgfr2-IIIb splice switch in kidney development | Mouse | High |
| PMID: 40086870 (2025) | Review / primary | Qualifies (MF context) | Scope of activity | ESRP1 regulates alternative splicing and mRNA stability | Inner ear | Medium; implies cytoplasmic mRNA-stability role |
How the evidence supports vs. challenges the prediction. The prediction is supported directly by the human-ortholog experimental IDA (nucleus) and by the mechanistic requirement that a splicing regulator act on nuclear pre-mRNA (PMIDs 26371508, 30485810, 27404344, 40086870 establish ESRP1 as a bona fide splicing/RNA-processing regulator). It is qualified — not refuted — by PMID 28634384, which shows ESRP1 is nucleocytoplasmic with a conserved cytoplasmic isoform pool. No evidence refutes nuclear localization.
Summary GO decision table:
| GO term | Aspect | Recommended action | Evidence code | Basis |
|---|---|---|---|---|
| nucleus (GO:0005634) | CC | Retain | ISS | Human ESRP1 nucleus IDA; ortholog ~78% id |
| nucleoplasm (GO:0005654) | CC | Consider adding (more specific) | ISS | Human ESRP1 IDA (HPA) |
| nuclear body (GO:0016604) | CC | Consider adding (more specific) | ISS | Human ESRP1 IDA (HPA) |
| cytoplasm (GO:0005737) | CC | Consider as lead | ISS | Conserved cytoplasmic isoforms (PMID 28634384) |
| sequence-specific mRNA binding | MF | Add as core | ISS | 3 intact ESRP-type RRMs |
| regulation of alternative mRNA splicing (GO:0000381) | BP | Add as core | ISS | ESRP1 family function (PMIDs 26371508, 28634384) |
| any membrane/secreted CC | CC | Do not add | — | 0 TM segments; soluble RBP |
The direct molecular activity is sequence-specific RNA binding via three RRMs, promoting epithelial-specific alternative splicing of target pre-mRNAs (e.g., FGFR2, CD44, ENAH, Arhgef11) in the nucleus. The nucleus CC term captures the site of this direct splicing activity.
The following are downstream of the direct nuclear activity and should not be conflated with the localization annotation: epithelial tight-junction integrity via Arhgef11 splicing (PMID 30485810); ureteric branching and nephron number via Fgfr2-IIIb splicing (PMID 27404344); cleft lip/palate and epidermal barrier defects in Esrp knockouts (PMID 26371508); and mRNA-stability/inner-ear roles (PMID 40086870). These confirm ESRP1 is a functionally important nuclear splicing regulator but are developmental/loss-of-function outcomes, not evidence for the CC term itself. The CC term rests on direct localization data (human IDA) plus the mechanistic requirement of nuclear pre-mRNA access.
All localization evidence derives from mammalian/Drosophila orthologs plus sequence computation; there is no elephant-shark-specific experimental data, and GO annotations remain electronic/orthology-based for this species.
The most efficient tests to distinguish "nucleus (dominant)" from "nucleocytoplasmic/cytoplasmic" alternatives:
The ProtNLM2 nucleus (GO:0005634) prediction for elephant shark A0A4W3GVU1 is SUPPORTED. The protein is an unambiguous ESRP1 ortholog (~78% identity to human ESRP1 vs ~60% to ESRP2), a soluble RNA-binding protein with three intact ESRP-type RRMs and no transmembrane segments, and its human ortholog carries direct experimental nuclear localization — giving a sound ISS basis for nucleus as the primary localization. The one substantive caveat is that ESRP1 is functionally nucleocytoplasmic (a conserved cytoplasmic isoform pool; PMID 28634384), so nucleus is dominant but not exclusive, and the prediction is coarser than the more specific ortholog CC terms and the true core MF/BP terms.